インテリジェント喘息モニタリングデバイスの市場規模、シェア、成長分析：製品別、最終用途別、地域別 - 産業予測 2025～2032年

インテリジェント喘息モニタリングデバイスの世界市場規模は2023年に6億4,596万米ドルとなり、予測期間（2025～2032年）のCAGRは25.6%で、2024年の8億1,133万米ドルから2032年には50億2,473万米ドルに成長する見通しです。

インテリジェント喘息モニタリングデバイスの世界市場は、大気汚染の増加、室内空気汚染物質の影響を受けやすい人の増加、COPDと喘息の顕著な増加により、著しい成長を遂げています。この拡大を促進する主な要因には、スマート吸入器のアドヒアランス強化、患者中心のケアへのシフト、製薬会社とスマート吸入器メーカーとの提携などがあります。先進的なデジタル機器は現在、ユーザーに喘息発作の可能性を警告し、アドヒアランスを効果的にモニターし、個人用機器へのデータ・トランスミッションを容易にし、投与時間を綿密に記録します。モバイルヘルスアプリケーション、ウェアラブル、個人モニタリング技術の統合は、喘息管理を改善するための大きな可能性を秘めており、これらの技術革新を呼吸器疾患との継続的な戦いにおける重要な要素として位置づけています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次データと一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• 規制情勢
• ケーススタディ
• 技術の進歩
• 貿易分析

インテリジェント喘息モニタリングデバイス市場規模：製品別

• 市場概要
• ウェアラブル喘息モニタリングデバイス
• スマート吸入器
• 吸入器
• 乾燥粉末吸入器（DPI）
• 定量噴霧式吸入器（MDI）
• ネブライザー

インテリジェント喘息モニタリングデバイス市場規模：最終用途別

• 市場概要
• 病院
• クリニック
• 家庭用
• その他

インテリジェント喘息モニタリングデバイス市場規模

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 市場の最近の動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 会社概要
  • 製品ポートフォリオ分析
  • セグメント別シェア分析
  • 収益の前年比比較（2022～2024年）

主要企業プロファイル

• Adherium Limited（New Zealand）
• AstraZeneca plc（United Kingdom）
• Boehringer Ingelheim International GmbH（Germany）
• Cohero Health, Inc.（United States）
• GlaxoSmithKline plc（United Kingdom）
• Health Care Originals, Inc.（United States）
• Koninklijke Philips N.V.（Netherlands）
• Teva Pharmaceutical Industries Ltd.（Israel）
• Vectura Group plc（United Kingdom）
• Volansys Technologies Pvt. Ltd.（India）
• 3M（United States）
• AEvice Health（Singapore）
• Respiri Limited（Australia）
• Quvium（United States）
• Findair（Poland）
• Sensirion AG（Switzerland）
• Thorasys Thoracic Medical Systems Inc.（Canada）
• Vitalograph Ltd.（Ireland）
• Zephyr Sleep Technologies（Canada）

結論と推奨事項

Global Intelligent Asthma Monitoring Devices Market size was valued at USD 645.96 million in 2023 and is poised to grow from USD 811.33 million in 2024 to USD 5024.73 million by 2032, growing at a CAGR of 25.6% during the forecast period (2025-2032).

The global market for intelligent asthma monitoring devices is experiencing significant growth due to rising air pollution, an increase in individuals vulnerable to indoor air contaminants, and a notable upsurge in COPD and asthma cases. Key factors driving this expansion include enhanced adherence to smart inhalers, a shift towards patient-centered care, and partnerships between pharmaceutical firms and smart inhaler producers. Advanced digital devices now alert users to potential asthma attacks, effectively monitor adherence, and facilitate the transmission of data to personal devices, meticulously documenting dosing times. The integration of mobile health applications, wearables, and personal monitoring technologies holds tremendous potential for improving asthma management, positioning these innovations as critical components in the ongoing battle against respiratory conditions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Intelligent Asthma Monitoring Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Intelligent Asthma Monitoring Devices Market Segmental Analysis

Global Intelligent Asthma Monitoring Devices Market is segmented by product, end use and region. Based on product, the market is segmented into wearable asthma monitoring devices, smart inhalers, inhalers, dry powdered inhalers (DPI's), metered dose inhalers (MDI's) and nebulizers. Based on end use, the market is segmented into hospitals, clinics, home use and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Intelligent Asthma Monitoring Devices Market

The global market for intelligent asthma monitoring devices is experiencing significant growth, primarily driven by the rising prevalence of asthma and the growing adoption of smart inhalers. Increasing levels of pollution worldwide contribute to a higher incidence of asthma, thereby driving demand for these advanced monitoring solutions. According to the Centers for Disease Control and Prevention (CDC), over 27 million people in the U.S. are affected by asthma, with a notable prevalence among children. Asthma UK's estimates suggest there are over 300 million individuals suffering from this condition, and this figure is projected to exceed 400 million by 2025. The heightened awareness of the benefits of asthma monitoring devices, alongside technological advancements and increased focus from companies on developing smart inhalers-such as dry powder and metered dose inhalers-are essential factors fueling market growth. Key industry players are leveraging these innovations to improve asthma management and enhance the efficacy of prescribed treatments.

Restraints in the Global Intelligent Asthma Monitoring Devices Market

The Global Intelligent Asthma Monitoring Devices market faces significant restraints, particularly stemming from a lack of awareness regarding the effective utilization of smart inhalers and nebulizers. As pollution levels continue to rise globally, the incidence of asthma cases escalates, highlighting the urgent need for innovative and affordable monitoring devices that empower patients to actively engage in self-monitoring practices. However, the prevailing ignorance about how to properly use these advanced devices limits their adoption and effectiveness, ultimately hindering the overall growth of the intelligent asthma monitoring market. Addressing this knowledge gap is crucial for enhancing patient outcomes and market expansion.

Market Trends of the Global Intelligent Asthma Monitoring Devices Market

The Global Intelligent Asthma Monitoring Devices market is witnessing a significant upward trend, driven by the rising prevalence of asthma and respiratory conditions. Wearable technologies like the ADAMM smart patch exemplify this innovation, offering real-time monitoring of vital symptoms such as cough, respiration rate, and wheezing. These devices not only alert users with vibrations upon detecting deviations from individual norms but also enhance patient safety by sending notifications to caregivers. As healthcare increasingly adopts digital solutions for chronic disease management, the demand for such intelligent monitoring devices is expected to surge, heralding a transformative era in asthma care and patient autonomy.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technological Advancement
• Trade Analysis

Global Intelligent Asthma Monitoring Devices Market Size by Product & CAGR (2025-2032)

• Market Overview
• Wearable Asthma Monitoring Devices
• Smart Inhalers
• Inhalers
• Dry Powdered Inhalers (DPI's)
• Metered Dose Inhalers (MDI's)
• Nebulizers

Global Intelligent Asthma Monitoring Devices Market Size by End Use & CAGR (2025-2032)

• Market Overview
• Hospitals
• Clinics
• Home Use
• Others

Global Intelligent Asthma Monitoring Devices Market Size & CAGR (2025-2032)

• North America (Product, End Use)
  • US
  • Canada
• Europe (Product, End Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, End Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, End Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, End Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Adherium Limited (New Zealand)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AstraZeneca plc (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boehringer Ingelheim International GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cohero Health, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline plc (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Health Care Originals, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Koninklijke Philips N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical Industries Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vectura Group plc (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Volansys Technologies Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 3M (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AEvice Health (Singapore)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Respiri Limited (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quvium (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Findair (Poland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sensirion AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thorasys Thoracic Medical Systems Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vitalograph Ltd. (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zephyr Sleep Technologies (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations